An estimated 7.2 million Americans are living with Alzheimer’s dementia. The financial burden is immense: health and long-term care costs for people living with Alzheimer’s and other dementias are projected to reach $384 billion in 2025. ApexBio is focused on dramatically shifting this cost curve by enabling early, preventative intervention.
A world where neurodegenerative diseases are prevented before symptoms emerge, enabling truly restorative therapies that preserve cognition and quality of life.
At Apex Bio, we are committed to achieving what others consider impossible, by turning groundbreaking science into real patient-driven treatments.
